Patrick Amstutz
Founder bei MOLECULAR PARTNERS AG
Vermögen: 3 Mio $ am 30.04.2024
Profil
Patrick Amstutz is the founder of Molecular Partners AG, a company founded in 2004, where he holds the title of Chief Executive Officer & Director.
He is currently the Chief Executive Officer & Director at Molecular Partners, Inc. and the President at Swiss Biotech Association since 2017.
Dr. Amstutz has a doctorate degree from the University of Zurich and a graduate degree from the Swiss Federal Institute of Technology.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
MOLECULAR PARTNERS AG
2,02% | 31.12.2023 | 735 095 ( 2,02% ) | 3 Mio $ | 30.04.2024 |
Aktive Positionen von Patrick Amstutz
Unternehmen | Position | Beginn |
---|---|---|
MOLECULAR PARTNERS AG | Founder | 23.11.2004 |
Swiss Biotech Association
Swiss Biotech Association Miscellaneous Commercial ServicesCommercial Services Swiss Biotech Association operates as an industry association. The private company is based in Zurich, Switzerland. Michael Altorfer has been the CEO of the Swiss company since 2018. | President | 03.05.2022 |
Molecular Partners, Inc.
Molecular Partners, Inc. Pharmaceuticals: MajorHealth Technology Part of Molecular Partners AG, Molecular Partners, Inc. operates as a clinical-stage biopharmaceutical company. The private company is based in Cambridge, MA. The CEO of the company is Patrick Amstutz. | Chief Executive Officer | - |
Ausbildung von Patrick Amstutz
University of Zurich | Doctorate Degree |
Swiss Federal Institute of Technology | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
MOLECULAR PARTNERS AG | Health Technology |
Private Unternehmen | 2 |
---|---|
Swiss Biotech Association
Swiss Biotech Association Miscellaneous Commercial ServicesCommercial Services Swiss Biotech Association operates as an industry association. The private company is based in Zurich, Switzerland. Michael Altorfer has been the CEO of the Swiss company since 2018. | Commercial Services |
Molecular Partners, Inc.
Molecular Partners, Inc. Pharmaceuticals: MajorHealth Technology Part of Molecular Partners AG, Molecular Partners, Inc. operates as a clinical-stage biopharmaceutical company. The private company is based in Cambridge, MA. The CEO of the company is Patrick Amstutz. | Health Technology |